Landscape Analysis of Phase 2 and 3 Clinical Trials for Targeted Radionuclide Therapy
- 12 February 2021
- journal article
- editorial
- Published by Society of Nuclear Medicine in Journal of Nuclear Medicine
- Vol. 62 (8), 1031-1032
- https://doi.org/10.2967/jnumed.120.258103
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Phase I Trial of 131I-GMIB-Anti-HER2-VHH1, a New Promising Candidate for HER2-Targeted Radionuclide Therapy in Breast Cancer PatientsJournal of Nuclear Medicine, 2020
- Preclinical Pharmacokinetics and Dosimetry Studies of 124I/131I-CLR1404 for Treatment of Pediatric Solid Tumors in Murine Xenograft ModelsJournal of Nuclear Medicine, 2019
- PSMA ligands in prostate cancer – Probe optimization and theranostic applicationsMethods, 2017